Novavax, Inc. (NASDAQ:NVAX) share price plunged -0.34% or -0.003 points to reach at $0.827 during previous trading session. The stock’s price fluctuated within the range of $0.82 – $0.87 during previous trading session. A total of 5.76M shares exchanged hands, whereas the company’s average trading volume stands at 6.11M shares. Novavax, Inc. (NASDAQ:NVAX) has a market capitalization of $211.10M and most recently 271.95M outstanding shares have been calculated.
In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.
Relative strength index (RSI-14) for Novavax, Inc. (NASDAQ:NVAX) is at 19.57.
According to sentiments of 6 analysts the mean estimates of short term price target for the company’s stock is marked at $3.58. The most optimistic analyst sees the stock reaching $12 while the most conventional predicts the target price at $3.58.
The consensus mean EPS for the current quarter is at $-0.17 derived from a total of 7 estimates. According to analysts minimum EPS for the current quarter is expected at $-0.19 and can go high up to $-0.13. However a year ago during same quarter Novavax, Inc. (NASDAQ:NVAX) reported $-0.29 EPS.
For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $-0.16 per share according to consensus of 7analysts.
According to sentiments of 6 analysts the company is expected to report revenues of $6.17M for the current quarter. Bearish revenue estimates established at $4M while the bullish revenue forecast has been figured out at $9M.
In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.62 on the shares of Novavax, Inc. (NASDAQ:NVAX). Out of rating recommendations 1 have given the stock a Buy while 1 recommend the stock as Outperform. 6 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.
On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Novavax, Inc. (NASDAQ:NVAX)’s distance from 20 day simple moving average is -24.47% whereas its distance from 50 day simple moving average is -36.08% along with -72.48% distance from 200 day simple moving average.
An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Novavax, Inc. (NASDAQ:NVAX) shares were trading -90.26% below from the 52-week high mark of $8.49 and +13.25% above from the 52-week bottom of $0.73. The stock hit its 52-week high price on 09/15/16 and 52-week low price on 04/06/17.
When we have a peek on stock’s historical trends we come to know that, the stock has slipped –7.11% in the past one week and plunged -37.37% during previous one month drive, the stock went down -41.78% during past quarter. In the last six months the stock’s performance fell -45.97% while yearly performance of the company fell -84.46%.The company’s year to date (YTD) performance is at -34.39%.
While taking a glance at financials, we can look at a number of key indicators. Novavax, Inc. (NASDAQ:NVAX) has a Return on Assets (ROA) of -56.80%. The company currently has a Return on Equity (ROE) of -329.60%. Average true range (ATR-14) of the company sets at 0.08, along with its weekly and monthly volatility of 7.12%, 9.10% respectively. Beta value of the stock stands at 2.13.
The company’s quick ratio for most recent quarter is 4.30 along with current ratio for most recent quarter of 4.30.